Vertex Pharmaceuticals (VRTX) Total Debt (QoQ) (2010 - 2017)
Analysis
Vertex Pharmaceuticals (VRTX) Total Debt (QoQ) (2010 - 2017) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.70 Bn | 58.52 Bn | 1.37 Bn |
| 4 | Moderna | 57.56 Bn | 52.42 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 40.16 Bn | 35.06 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.63 Bn | 32.32 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.63 Bn | 27.79 Bn | - |
| 9 | Insmed | 27.73 Bn | 26.57 Bn | 358.27 Mn |
| 10 | Incyte | 25.60 Bn | 21.07 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | 22.14% |
| Sep 30, 2017 | 28.84% |
| Jun 30, 2017 | 40.96% |
| Mar 31, 2017 | -71.94% |
| Dec 31, 2016 | 25.41% |
| Sep 30, 2016 | 0.42% |
| Jun 30, 2016 | 0.23% |
| Mar 31, 2016 | 0.22% |
| Dec 31, 2015 | 0.11% |
| Sep 30, 2015 | 0.01% |
| Jun 30, 2015 | 0.01% |
| Mar 31, 2015 | 0.01% |
| Dec 31, 2014 | 0.01% |
| Mar 31, 2011 | 31.29% |
| Dec 31, 2010 | 374.36% |
| Sep 30, 2010 | -72.33% |